NPI: 1821065947 · MIAMI, FL 33125 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,906 | $3.99M |
| 2019 | 28,300 | $5.29M |
| 2020 | 25,440 | $4.57M |
| 2021 | 15,388 | $984K |
| 2022 | 5,618 | $569K |
| 2023 | 3,192 | $250K |
| 2024 | 1,370 | $109K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,506 | 1,947 | $4.56M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,273 | 1,199 | $4.43M |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,065 | 1,284 | $3.09M |
| A4657 | Syringe, with or without needle, each | 3,955 | 1,379 | $823K |
| J1756 | Injection, iron sucrose, 1 mg | 5,345 | 841 | $661K |
| J0606 | Injection, etelcalcetide, 0.1 mg | 2,205 | 118 | $581K |
| 83970 | 1,631 | 1,018 | $269K | |
| 82728 | 1,623 | 1,018 | $269K | |
| 83540 | 1,617 | 1,020 | $258K | |
| 83550 | 1,598 | 1,014 | $253K | |
| 85041 | 1,439 | 908 | $235K | |
| 85048 | 1,403 | 886 | $233K | |
| 90674 | 59 | 47 | $24K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 89 | 47 | $19K |
| G0008 | Administration of influenza virus vaccine | 87 | 71 | $19K |
| 85045 | 63 | 51 | $18K | |
| 82108 | 92 | 61 | $18K | |
| 82607 | 17 | 15 | $6K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 123 | 48 | $1K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 24 | 13 | $0.00 |